Is OPKO Health Inc (OPK) a good stock to buy?
Find the latest OPKO Health, Inc. (OPK) stock quote, history, news and other vital information to help you with your stock trading and investing.
Is OPKO stock undervalued or overvalued?
Get the latest OPKO Health, Inc. (OPK) stock news and headlines to help you in your trading and investing decisions.
What is the OPK stock price prediction for 2026-09-07?
OPKO Health, Inc. Common Stock (OPK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
When is OPKO Health's next quarterly earnings release?
Apr 08, 2022 · The Opko Health Inc stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Is OPK stock a good buy?
Is OPKO HEALTH Stock a good buy in 2022, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: OPK) stock is to Buy OPK stock.
What does OPK company do?
A Diverse Healthcare Company Focused on Improving Patient Lives. At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions.
What kind of company is OPK?
OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK"....OPKO Health.TypePublicIndustryMedical Appliances & EquipmentFounded1991HeadquartersMiami, FloridaProductsMedical Products4 more rows
Why is OPK stock falling?
OPKO Health (NASDAQ:OPK), a healthcare company focused on diagnostics and pharmaceuticals, is trading ~10% lower in the post-market Thursday after indicating a mixed performance with its Q4 2021 results amid falling COVID-19 testing volumes.Feb 24, 2022
Will OPK stock go up?
Stock Price Forecast The 4 analysts offering 12-month price forecasts for OPKO Health Inc have a median target of 6.75, with a high estimate of 8.50 and a low estimate of 5.50. The median estimate represents a +95.65% increase from the last price of 3.45.
When did Opk go public?
The Company expects its common stock will begin trading on the NASDAQ Global Select Market (“NASDAQ”) on June 24, 2016, and its shares will continue to trade under the ticker symbol “OPK.”Jun 13, 2016
Who owns Opko Health Inc?
Dr. Phillip FrostAt OPKO Health, the entrepreneurial acumen of our founder and CEO, Dr. Phillip Frost, has led to the development of a diverse healthcare company flexible enough to adapt to evolving patient needs.
What does Opk stand for in pregnancy?
Ovulation predictor kits (OPKs) contain at-home tests that measure LH levels in the urine. It is best to start testing levels when the fertile window is drawing near, or a handful of days before ovulation. Most people ovulate between 7 and 19 days before their next period begins.Aug 31, 2018
What is Opk in pregnancy?
An ovulation test — also called an ovulation predictor test, OPK, or ovulation kit — is a home test that checks your urine to let you when you're most likely to be fertile. When you get ready to ovulate — release an egg for fertilization — your body produces more luteinizing hormone (LH).Feb 22, 2021
Is OPKO Health a buy right now?
What stocks does MarketBeat like better than OPKO Health?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OPKO Health in the last twelve months. There are currently 2 buy ratings for the stock.
When is OPKO Health's next earnings date?
Wall Street analysts have given OPKO Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but OPKO Health wasn't one of them.
How were OPKO Health's earnings last quarter?
OPKO Health is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.#N#View our earnings forecast for OPKO Health.
How has OPKO Health's stock price been impacted by Coronavirus?
OPKO Health, Inc. (NASDAQ:OPK) issued its quarterly earnings data on Thursday, July, 29th. The biotechnology company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.02 by $0.05. The biotechnology company had revenue of $442.40 million for the quarter, compared to analysts' expectations of $457.57 million.
What price target have analysts set for OPK?
OPKO Health's stock was trading at $1.69 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OPK stock has increased by 110.7% and is now trading at $3.56.#N#View which stocks have been most impacted by COVID-19.
What is Philip Frost's approval rating as OPKO Health's CEO?
2 brokerages have issued 12 month price objectives for OPKO Health's shares. Their forecasts range from $6.00 to $7.00. On average, they anticipate OPKO Health's share price to reach $6.50 in the next year.
OPKO Health's (OPK) Arm Boosts Prenatal Screening With Buyout
21 employees have rated OPKO Health CEO Philip Frost on Glassdoor.com. Philip Frost has an approval rating of 16% among OPKO Health's employees. This puts Philip Frost in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
OPKO Health's, Inc. (NASDAQ:OPK) CEO is on a Buying Spree Before the US Drug Approval Decision
OPKO Health's (OPK) BioReference's acquisition to expand its NIPS offerings and thereby enhance prenatal screening.
Midday Market Update: Why Are Stocks Down Today?
OPKO Health, Inc. (NASDAQ:OPK) a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. Their CEO has been continuously buying shares, and we were curious as to why that might be.
OPKO Health's (OPK) Q2 Earnings Lag Estimates, Margins Down
The stock market isn’t doing so hot on Friday as market worries continue to weigh on investors in our midday update. Source: Shutterstock There’s no getting around the fact that fears of the delta variant of the novel coronavirus are spreading. In addition to that, investors also have concerns when it comes to inflation and the rest of the market.
Opko Health (OPK) Q2 2021 Earnings Call Transcript
OPKO Health's (OPK) second-quarter results benefit from strength in both its reportable segments.
OPKO Health (OPK) Reports Q2 Loss, Misses Revenue Estimates
Image source: The Motley Fool. Opko Health (NASDAQ: OPK)Q2 2021 Earnings CallJul 29, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood afternoon, ladies and gentlemen, and welcome to the OPKO Health second-quarter 2021 financial results conference call.
Earnings Preview: OPKO Health (OPK) Q2 Earnings Expected to Decline
OPKO Health (OPK) delivered earnings and revenue surprises of -250.00% and -3.31%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Signals & Forecast
OPKO Health (OPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Opko Health Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock.
Is Opko Health Inc stock A Buy?
Opko Health Inc finds support from accumulated volume at $3.61 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
OPKO Health, Inc. (OPK)
Opko Health Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Style Scorecard
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Chart for OPK
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
Why are people shorting OPKO Health?
Headquartered in Miami, Florida, OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico.
Micro-cap fraudster?
OPKO Health is a battleground stock because the company is the investment arm of Phillip Frost. Frost is a self-made billionaire and doctor, who became one of the richest people in the world when he sold his generic drug company, Ivax, to Teva Pharmaceuticals for $7.6 billion in 2005.
Business
- Opko Health is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Opko Health.
Risks
- 2 equities research analysts have issued 1-year target prices for Opko Health's stock. Their predictions range from $5.00 to $20.00. On average, they anticipate Opko Health's share price to reach $12.50 in the next year. This suggests a possible upside of 489.6% from the stock's current price. View Analyst Price Targets for Opko Health.
Ratings
- 2 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Opko Health in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of \"Buy.\" View Analyst Ratings for Opko Health.
Reception
- Headlines about OPK stock have trended neutral this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Opko Health e…
Ownership
- Opko Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.90%), Dimensional Fund Advisors LP (0.70%), Wells Fargo & Company MN (0.24%), RK Asset Management LLC (0.19%), Fosun International Ltd (0.14%) and Pictet Asset Management Ltd. (0.11%). Company insiders that ow...
Operations
- Opko Health has a market capitalization of $1.31 billion and generates $990.30 million in revenue each year. The biotechnology company earns $-153,040,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis. Opko Health employs 5,690 workers across the globe.
Access
- Opko Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The biotechnology company can be reached via phone at 305-575-4100 or via email at mmiller@lhai.com.